Hossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell, Mehrnaz Mostafavi, Farhan Shakil, Ehsan Safaee, Sancy A Leachman, Alireza Haghighi, Michelle Tarbox, Chritopher G Bunick, Ayman Grada
{"title":"加强数字双胞胎的随机临床试验。","authors":"Hossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell, Mehrnaz Mostafavi, Farhan Shakil, Ehsan Safaee, Sancy A Leachman, Alireza Haghighi, Michelle Tarbox, Chritopher G Bunick, Ayman Grada","doi":"10.1038/s41540-025-00592-0","DOIUrl":null,"url":null,"abstract":"<p><p>Digital twins (DTs) can transform randomized clinical trials by improving ethical standards, including safety, informed consent, equity, and data privacy. They also enhance trial efficiency by enabling early detection of adverse events and streamlined design. This paper explores the role of DTs in personalized medicine, from pre-clinical research to post-marketing, while addressing technological, legal, and ethical challenges in implementation.</p>","PeriodicalId":19345,"journal":{"name":"NPJ Systems Biology and Applications","volume":"11 1","pages":"110"},"PeriodicalIF":3.5000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494699/pdf/","citationCount":"0","resultStr":"{\"title\":\"Enhancing randomized clinical trials with digital twins.\",\"authors\":\"Hossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell, Mehrnaz Mostafavi, Farhan Shakil, Ehsan Safaee, Sancy A Leachman, Alireza Haghighi, Michelle Tarbox, Chritopher G Bunick, Ayman Grada\",\"doi\":\"10.1038/s41540-025-00592-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Digital twins (DTs) can transform randomized clinical trials by improving ethical standards, including safety, informed consent, equity, and data privacy. They also enhance trial efficiency by enabling early detection of adverse events and streamlined design. This paper explores the role of DTs in personalized medicine, from pre-clinical research to post-marketing, while addressing technological, legal, and ethical challenges in implementation.</p>\",\"PeriodicalId\":19345,\"journal\":{\"name\":\"NPJ Systems Biology and Applications\",\"volume\":\"11 1\",\"pages\":\"110\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494699/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Systems Biology and Applications\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1038/s41540-025-00592-0\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MATHEMATICAL & COMPUTATIONAL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Systems Biology and Applications","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s41540-025-00592-0","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
Enhancing randomized clinical trials with digital twins.
Digital twins (DTs) can transform randomized clinical trials by improving ethical standards, including safety, informed consent, equity, and data privacy. They also enhance trial efficiency by enabling early detection of adverse events and streamlined design. This paper explores the role of DTs in personalized medicine, from pre-clinical research to post-marketing, while addressing technological, legal, and ethical challenges in implementation.
期刊介绍:
npj Systems Biology and Applications is an online Open Access journal dedicated to publishing the premier research that takes a systems-oriented approach. The journal aims to provide a forum for the presentation of articles that help define this nascent field, as well as those that apply the advances to wider fields. We encourage studies that integrate, or aid the integration of, data, analyses and insight from molecules to organisms and broader systems. Important areas of interest include not only fundamental biological systems and drug discovery, but also applications to health, medical practice and implementation, big data, biotechnology, food science, human behaviour, broader biological systems and industrial applications of systems biology.
We encourage all approaches, including network biology, application of control theory to biological systems, computational modelling and analysis, comprehensive and/or high-content measurements, theoretical, analytical and computational studies of system-level properties of biological systems and computational/software/data platforms enabling such studies.